Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
Clinical trial NCT00807235 · TERMINATED
Trial details
- NCT number
- NCT00807235
- Sponsor
- Windtree Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2005-08-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.